Partner With Us
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
As the only event exclusively dedicated to glioblastoma drug development, this conference offered an unparalleled opportunity for industry leaders to engage with top experts from every corner of the GBM space. Attendees included key figures from large pharma, biotech, neuro-oncology, clinical practice, investment, and academia—all focused on driving progress in glioblastoma treatment. With a growing demand for innovative models, diagnostics, and delivery technologies, this forum was the ideal setting to identify market gaps that products and services could address.
Recent breakthroughs, such as the positive results for IDH-2 mutant low-grade glioma therapies, sparked renewed optimism within the GBM research community. As the field approached a critical turning point, there was momentum for a major shift in how glioblastoma and other CNS tumors were treated.
This event provided a unique chance to position companies at the forefront of these developments, aligning with the most cutting-edge research and development in neuro-oncology. It was the perfect moment to establish valuable partnerships and showcase contributions to advancing transformative solutions for one of the most challenging areas of oncology. Attendees joined us and became part of a movement that was changing the future of GBM treatment.
Why Partner In 2026:
 |
Providing unparalleled opportunities for high-level networking with influential decision-makers and pioneers driving the future of GBM research and treatment innovation, this event stands as the exclusive forum entirely dedicated to glioblastoma, making it the premier gathering for experts in the field. |
 |
Position your brand in front of key neuro-oncology professionals who are actively seeking innovative services, unlocking new business prospects and fostering valuable connections with industry leaders. |
 |
With the field facing unique hurdles and an urgent demand for solutions, the market is open to novel approaches, and this event offers a prime stage to demonstrate how your preclinical models, delivery solutions & diagnostic technology can provide essential insights, support drug development, and improve treatment outcomes, positioning your solutions as key to advancing the field. |
Who You Could Meet?
